Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03535961
Brief Title: Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

First Submitted : September 10, 2017
First Submitted that Met QC Criteria : May 23, 2018
First Posted : May 24, 2018

Last Update Submitted that Met QC Criteria : December 1, 2020
Last Update Posted : December 2, 2020